Pacific Biosciences of California, Inc. (PACB) Posts Q3 Loss of 41c/Share

Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q3 EPS of ($0.41), $0.02 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $3.12 million.

For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Cloudastructure restructures preferred stock, issues $1.3M promissory note
• JPMorgan Starts Zensho Holdings (7550:JP) at Overweight